Protein tyrosine phosphatase inhibitors
OwnerBrent Townshend, Michel Tremblayinventors
Life of this patent
Estimating the term…
Abstract
The present invention provides compositions and methods for binding and/or modulating enzymatic activity of human protein tyrosine phosphatases such as PTP1B. Additionally, the invention provides methods of identifying and using such nucleic acid ligands.
Claims47
A non-naturally occurring nucleic acid ligand that exhibits binding specificity to a human protein tyrosine phosphatase.
An inhibitor of human protein tyrosine phosphatase 1B (PTP1B), wherein the inhibitor reduces a phosphatase activity of PTP1B at least 50 times more strongly than a phosphatase activity of TC-PTP.
An inhibitor of human protein tyrosine phosphatase 1B (PTP1B), wherein the inhibitor reduces a phosphatase activity of PTP1B at least 10 times more strongly than a phosphatase activity of TC-PTP and further wherein the inhibitor is characterized by a Ki of less than 100 nM.
A complex of a non-naturally occurring nucleic acid ligand and a human protein tyrosine phosphatase.
A polynucleotide collection comprising a plurality of nucleic acids of which at least one nucleic acid molecule comprises a ribonucleic acid sequence and exhibits binding specificity to a human protein tyrosine phosphatase.
A polynucleotide comprising a sequence exhibiting at least 60% sequence identity to any of the sequences of Table 3.
Dependencies are inferred from the claim text.